Phase II study of mitoguazone in pancreatic cancer: a Southwest Oncology Group Study.
M S
MS
Inamasu
N
N
Oishi
T T
TT
Chen
E H
EH
Kraut
P N
PN
Grozea
J J
JJ
Costanzi
J D
JD
Bonnet
D000328:Adult; D000368:Aged; D004341:Drug Evaluation; D006801:Humans; D008875:Middle Aged; D008935:Mitoguazone / Q000009:adverse effects / Q000627:therapeutic use*; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000473:pathology
D008935:Mitoguazone